Dr. John Corboy, MD
Neurology (Neurology Physician)
12605 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 132
Licensed in Colorado since 1994, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CO license 33605 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 132
- Services billed
- 148
- Patients’ average age
- 64
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 93 | 86 |
| Established patient office or other outpatient visit, 40-54 minutes | 55 | 52 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Aurora, CO | 108 |
| Baclofen Other prescribers in Aurora, CO | 100 |
| Tizanidine Hcl Other prescribers in Aurora, CO | 65 |
| Dalfampridine Er (dalfampridine) | 64 |
| Clonazepam Other prescribers in Aurora, CO | 35 |
| Fingolimod (fingolimod hcl) | 32 |
| Modafinil Other prescribers in Aurora, CO | 30 |
| Pregabalin Other prescribers in Aurora, CO | 28 |
| Gammagard Liquid (immun glob g(igg)/gly/iga ov50) | 24 |
| Duloxetine Hcl Other prescribers in Aurora, CO | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,052 in research payments for these studies, mostly to the institutions running them.
- A multicenter randomized double blind parallel group placebo controlled variable treatment duration study evaluating the efficacy and safety of Siponimod BAF312 in patients with secondary progressive multiple sclerosis
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.